Filter posts

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

Happy 91st Birthday Senator Bayh!

At its best, government enables citizens to flourish socially and economically. Above and beyond the …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative‚Äôs (USTR) negotiations with the Government of Japan as an …

Drug Importation: Dangerous for Patients, Consumers, and American Communities

Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a …

USMCA Paves the Way for Biotech Innovation

After more than a year of high-stakes drama, the U.S. has inked an updated trade …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

Bipartisan SUCCESS Act is Good for American Innovation

Last week, the House Judiciary Committee unanimously reported the bipartisan SUCCESS Act. Co-sponsored by Representatives …

New Documentary Highlights Consequences of Bad Patent Laws

The U.S. leads the world in biotech innovation, delivering solutions to combat debilitating and rare …

TROL Act Reintroduced in House

Strong patents are the lifeblood of the biotech industry. They are critical in ensuring a …

BIO Comments on Proposed PTO Rules Change

The United States Patent and Trademark Office (PTO) is currently considering a rules change that, …